Current Cancer Drug Targets
Title:Meet Our Executive Guest Editor
Volume: 20 Issue: 4
Author(s): C. Xu
Affiliation:
Export Options
About this article
Cite this article as:
Xu C. , Meet Our Executive Guest Editor, Current Cancer Drug Targets 2020; 20 (4) . https://dx.doi.org/10.2174/156800962004200430123432
DOI https://dx.doi.org/10.2174/156800962004200430123432 |
Print ISSN 1568-0096 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5576 |
23
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Targeting the Perpetrator: Breast Cancer Stem Cell Therapeutics
Current Drug Targets Pharmacogenomic Approaches to Osteoporosis: 2005 Update
Current Pharmacogenomics The Expression, Function and Targeting of Haem Oxygenase-1 in Cancer
Current Cancer Drug Targets Patent Selections:
Recent Patents on Biotechnology Meet Our Editorial Board Member:
Current Cancer Therapy Reviews Respiration and Energy Homeostasis
Current Respiratory Medicine Reviews Recent Advances in Endocrine, Metabolic and Immune Disorders: Mesenchymal Stem Cells (MSCs) and Engineered Scaffolds
Endocrine, Metabolic & Immune Disorders - Drug Targets Multimerization Improves Targeting of Peptide Radio-Pharmaceuticals
Current Pharmaceutical Design Porous Silicon: A Resourceful Material for Nanotechnology
Recent Patents on Nanotechnology Prospects for Anti-Neoplastic Therapies Based on Telomere Biology
Current Cancer Drug Targets SUBJECT INDEX TO VOLUME 1
Current Drug Targets Deprescribing Antipsychotic Medications in Psychotic Disorders: How and Why?
Current Psychiatry Reviews Patent Selections:
Recent Patents on Anti-Cancer Drug Discovery Pharmaceutical Applications of Graphene-based Nanosheets
Current Pharmaceutical Biotechnology The Cholinergic Potential, the Vagus Nerve and Challenges in Treatment of Traumatic Brain Injury
Current Pharmaceutical Design Apoptosis: Mediator Molecules, Interplay with Other Cell Death Processes and Therapeutic Potentials
Current Pharmaceutical Biotechnology Therapeutic Approach to Patients with Chronic Lymphocytic Leukemia and Significant Comorbid Conditions
Current Cancer Drug Targets Painting the Target Around the Arrow: Two-Step Prodrug Therapies from a Carbohydrate Chemists Perspective
Current Drug Delivery Carbon Nanotubes: An Emerging Drug Delivery Carrier in Cancer Therapeutics
Current Drug Delivery Heparin, Heparan Sulfate and Heparanase in Cancer: Remedy for Metastasis?
Anti-Cancer Agents in Medicinal Chemistry